Agile Therapeutics reported $13.03M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Adma Biologics ADMA:US $ 52.42M 17.09M
Agile Therapeutics AGRX:US $ 13.03M 9.28M
Bayer BAYN:GR € 3412M 2373M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Pacira Pharmaceuticals PCRX:US $ 122.06M 104.69M
Pain Therapeutics PTIE:US $ 197.23M 12.46M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M